SIREN : 979394798
B+B PHARMA is a French company founded 2 years ago, specialized in the sector Activités des sociétés holding. Based in CHARTRES (28000), this company of category PME shows in 2025 a net income negative of -15€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Data updated on 2026-05-02
Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy
| Indicator | 2025 |
|---|---|
| Revenue | N/C |
| Net income | -15 € |
| EBITDA | N/C |
| Net margin | N/C |
In 2025, B+B PHARMA records a net loss of 15 €. This deficit will reduce equity on the balance sheet.
-15 €
The debt ratio (= Financial debt / Equity x 100) stands at 0%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 100%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
0.0%
100.0%
In 2025, the debt ratio of B+B PHARMA (0.00) ranks in the bottom 25% of the sector, which is positive. This ratio measures the weight of debt relative to equity. A low ratio indicates a solid financial structure with little dependence on creditors.
In 2025, the financial autonomy of B+B PHARMA (100.0%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.
Compare B+B PHARMA with other companies in the same sector:
Voir toutes les statistiques du secteur Activités des sociétés holding
The revenue of B+B PHARMA is not publicly disclosed (confidential accounts filed with INPI).
B+B PHARMA recorded a net loss in 2025.
The headquarters of B+B PHARMA is located in CHARTRES (28000), in the department Eure-et-Loir.
The tax return of B+B PHARMA is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
B+B PHARMA operates in the sector Activités des sociétés holding (NAF code 64.20Z). See the 'Sector positioning' section above to compare the company with its competitors.